A thioacrylamide-based compound directly counteracts hepatic fibrosis with profound anti-obesity action
Elisabeth Rohbeck(Deutsches Diabetes-Zentrum e.V.), Jürgen Eckel(Henkel (Germany)), Corinna Niersmann, Thorsten Wachtmeister(Heinrich Heine University Düsseldorf), D. Margriet Ouwens(German Center for Diabetes Research), Volker M. Lauschke(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Michael Roden(Düsseldorf University Hospital), Bedair Dewidar(Tanta University), Karl Köhrer(Heinrich Heine University Düsseldorf), Bruno Guigas(Leiden University Medical Center)
Cited by 0
Related Papers
<scp>TGF</scp>‐β signalling and liver disease
|FEBS Journal|2016|611
Myokines in insulin resistance and type 2 diabetes
|Diabetologia|2014|218
Adipose Dipeptidyl Peptidase-4 and Obesity
|Diabetes Care|2013|217